ONEDAYBIOTEC Implants, which have high technology, product compatibility, and early fixation, are certified by FDA, a government agency affiliated with DHHS in the United States for consumer protection.
ONEDAYBIOTEC Implants have obtained permission for imported items and have officially started selling them in the U.S. market by matching the sales registration. With the acquisition of dental implant fixture permits, ONEDAYBIOTEC is gaining ground in the global implant market.
Through constant clinical research, ONEDAYBIOTEC researches and develops dental implants that are convenient and fast and can maintain the life of implants for a long time, and with these efforts, it provides customized services that accommodate the needs of procedures.
The patented ONEDAYBIOTEC implant is an implant device that can preserve internal blood vessels by shielding the upper part of the implant while being treated in the area where the extraction is performed, facilitates quick and easy procedures, and reduces patient pain.
It is a certified implant that has conducted numerous clinical studies for vertical bone growth, bone tissue stabilization, ease of procedure, and postoperative stability.
Currently, we are making efforts to increase the success rate of implants by using the SLA surface treatment method developed by Straumann in Switzerland to ensure stable bone fusion, and we will do our best to research and develop implant products for more convenience.